Solu Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch Solu Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) (NCT06950034) | Solu Therapeutics, Inc | 2025-03-13 |
Track Solu Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.